Psychiatry Conference 2025 | Psychiatry Webinars

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

psychiatry conference 2025, psychiatry, psychiatry webinars, psychiatry conference, medical conferences, international conference, annual congress

Tomiki Sumiyoshi

National Center of Neurology and Psychiatry, Japan

psychiatry conference 2025, psychiatry, psychiatry webinars, psychiatry conference, medical conferences, international conference, annual congress

Dr. Prakash V Diwan

National Institute of Pharmaceutical Education and Research India Iceland

psychiatry conference 2025, psychiatry, psychiatry webinars, psychiatry conference, medical conferences, international conference, annual congress

Francisco Rodriguez Pulido

University of La Laguna, Spain

psychiatry conference 2025, psychiatry, psychiatry webinars, psychiatry conference, medical conferences, international conference, annual congress

Huicong Wang

Xuanwu Hospital of Capital Medical University, China

WORLD PSYCHIATRY 2025

About Conference


We are excited to announce the "6th Annual Congress on Psychiatry," set to take place on February 24-25, 2025 in Paris, France. This prestigious gathering will unite renowned psychiatrists, mental health professionals, researchers, educators, and students worldwide, fostering collaboration and intellectual exchange.

 WORLD PSYCHIATRY 2025 promises an enriching experience through keynote addresses from thought leaders, cutting-edge presentations, and ample networking opportunities. Attendees will engage in thought-provoking discussions, explore the latest advancements in psychiatry, and delve into innovative approaches to mental health care.

This event offers a valuable platform for building professional connections, sharing expertise, and contributing to the future of psychiatric practice. Focusing on pushing the boundaries of mental health research and treatment, participants will be inspired and better equipped to address the evolving challenges in the field. Join us in Paris for this remarkable event to shape the future of psychiatry!

Tracks

Track 01: Anxiety Disorders
Anxiety disorders are psychological problems marked by overwhelming fear, anxiety, or nervousness that interfere with day-to-day functioning. Panic disorder, social anxiety disorder, generalized anxiety disorder (GAD), and particular phobias are common varieties. These disorders can cause symptoms including shortness of breath, fast heartbeat, trouble concentrating, and physical manifestations.

Track 02: Attention-Deficit Hyperactivity Disorder (ADHD/ADD)
ADHD is a neurodevelopmental disease marked by impulsivity, hyperactivity, and trouble paying attention. It can hinder social, professional, and academic functioning in both adults and children. ADHD's ADD subtype is characterized by focus problems without hyperactivity. Medication, behavioral therapy, and helpful techniques for enhancing organization and focus are among the treatments. workouts and methods for reducing stress.

Track 03: Autism Spectrum Disorders (ASD)
Autism Spectrum Disorders describe a group of developmental disorders that impact behavior, social interaction, and communication. Although there is a wide range of symptoms, from moderate to severe, frequent difficulties include limited interests, repetitive habits, and trouble interpreting social cues. Results can be greatly enhanced by early intervention and therapies like speech and behavioral therapy.

Track 04: Bipolar Disorder (Manic-Depressive Illness)
Mania or hypomania, as well as depression, are dramatic mood swings caused by bipolar disorder, a mental health disease. These mood swings might have an impact on one's level of energy, activity, judgment, and clarity of thought. Mood stabilizers, psychotherapy, and lifestyle modifications are commonly used in treatment to control symptoms and avoid relapses.

Track 05: Borderline Personality Disorder
Borderline Personality Disorder (BPD) is a mental health disease characterized by fluctuating moods, behavior, and relationships. Individuals with BPD may have extreme emotional swings, a fear of abandonment, impulsive behavior, and a skewed self-image. Dialectical behavior therapy (DBT), in conjunction with medicine and professional mental health assistance, is a typical treatment.

Track 06: Depression
Depression is a common but significant mental health illness marked by persistent sorrow, hopelessness, and a loss of interest in formerly enjoyable activities. It can harm physical health by causing exhaustion, eating disorders, and sleep disruptions. To improve mood and daily functioning, psychotherapy, medication, and lifestyle changes are frequently used in conjunction.

Track 07: Disruptive Mood Dysregulation Disorder (DMDD)
A childhood disorder known as dissociative mood disorder (DMDD) is characterized by frequent, violent, and out-of-control outbursts of rage that are not appropriate for the circumstances. These kids could find it difficult to control their emotions, and they get quite frustrated easily. To help control mood and emotional reactions, treatment methods include behavioral therapy and occasionally medication.

Track 08: Eating Disorders
Eating disorders are serious mental health diseases marked by poor connections with food, body image, and weight. Common kinds include anorexia nervosa, bulimia nervosa, and binge eating disorder. These illnesses can cause serious physical health consequences and are treated with a combination of psychotherapy, nutritional counseling, and, in some cases, medication.

Track 09: Obsessive-Compulsive Disorder (OCD)
Obsessive-Compulsive Disorder (OCD) is an anxiety disorder marked by intrusive thoughts (obsessions) and ritualistic behaviors (compulsions) to mitigate distress. These actions can disrupt daily life and relationships. Treatment often includes cognitive-behavioral therapy, specifically exposure and response prevention, and medications like SSRIs to alleviate symptoms.

Track 10: Post-Traumatic Stress Disorder (PTSD)
A traumatic event might be experienced or witnessed, and then one can acquire Post-Traumatic Stress Disorder (PTSD). Flashbacks, nightmares, excruciating anxiety, and intrusive thoughts are among the symptoms. PTSD sufferers frequently make an effort to block out memories of the experience. Cognitive behavioral therapy (CBT) with a trauma focus and medication to assist control symptoms and enhance coping mechanisms are common treatments.

Track 11: Schizophrenia
Schizophrenia is a chronic mental illness that impairs one's thinking, emotions, and behavior. Common symptoms include hallucinations, delusions, disorganized thinking, and difficulties in daily functioning. While there is no cure for schizophrenia, it can be controlled with antipsychotic drugs, psychotherapy, and assistance from mental health specialists to enhance quality of life.

Track 12: Anger Management and Psychotherapeutics
Anger Management and Psychotherapeutics addresses the psychological mechanisms behind anger and explores therapeutic strategies to manage it. This track will focus on effective psychotherapeutic interventions, including cognitive-behavioral therapy, mindfulness, and emotional regulation techniques. It aims to equip professionals with the tools to help individuals manage anger constructively and reduce its negative impacts on mental health and relationships.

Track 13: Psychosomatic Medicine
Psychosomatic medicine explores the connection between the mind and body, examining how psychological factors can affect physical health. Stress, anxiety, and depression, for example, can contribute to or worsen physical conditions like hypertension, heart disease, and gastrointestinal issues. Treatments often involve managing both psychological and physical symptoms through a multidisciplinary approach.

Track 14: Psychopharmacology
Psychopharmacology is the study of how medications affect the mind, emotions, and behavior. It focuses on the use of psychiatric medications such as antidepressants, antipsychotics, and mood stabilizers to treat mental health disorders. Psychologists work closely with patients to adjust dosages and combinations of medications to achieve optimal therapeutic outcomes.

Track 15: Child Psychiatry
Child psychiatry focuses on diagnosing and treating mental, emotional, and behavioral disorders in children and adolescents. Common conditions include ADHD, autism, anxiety, and mood disorders. Treatment often involves a tailored combination of medication, psychotherapy, and family support to address the unique developmental needs and promote the well-being of young patients.

Track16: Geriatric Psychiatry
Geriatric psychiatry, often known as psychogeriatric, is a discipline of psychiatry that focuses on the mental health of older persons. It targets prevalent conditions among the aged, such as depression, anxiety, dementia, and late-life schizophrenia. Medication, therapy, and cognitive and emotional support are frequently used in combination to treat patients.

Track 17: Sports Psychology
Sports psychology examines the mental aspects of sports performance. It entails using psychological principles to help athletes improve motivation, focus, and emotional regulation. Sports psychologists help players build mental toughness, manage performance anxiety, and increase collaboration. This field is critical to improving both physical performance and mental health.

 

Participation Benefits

Benefits of Participation for Speakers

• Researchers are recognized globally for their contributions.

• Obtain credits for professional development.

• Explore cutting-edge analysis.

• Foster long-term relationships through social and networking events.

• Successfully promoted one page in abstract books and flyers, resulting in 1 million views and enhancing

   your research profile.

• Explore topics beyond Cell and Gene Therapy to broaden your knowledge and understanding.

• Our unique offering combines networking, learning, and enjoyment.

Benefits of Participation for Delegates

• Professional Development: Enhance understanding and knowledge.

• Attending webinars helps delegates feel supported, rejuvenated, and energized.

• Participating in our webinar will contribute to a new approach and ideology that can improve business and industry outcomes.

• Online webinars provide opportunities for researchers and specialists in Psychiatry and Mental Health to connect and share ideas.

Benefits of Participation for Sponsor

• Exposure to international markets may lead to the formation of new enterprises.

• Demonstrate your company's latest innovations, products, and services to worldwide attendees.

• Generate leads to increase business for our participants.

• Webinars on Psychiatry and Mental Health offer valuable insights to propel your firm forward.

• Advancing organizational plans through benchmarking.

• Attend our webinar to receive trustworthy input on your company's problems and challenges.

• Use your company's branding, marketing content, and advertising logo on webinar banners, websites, and other materials.

Benefits of the Association for Collaborators

• Developing long-term peer ties.

• Adding your organization's logo to our webinar banner, website, and other marketing materials can increase subscriber/membership by 40%.

• Our event will increase your company's visibility in the Global Business Forum, benefiting your association significantly.

• Representatives can enhance their knowledge of your organization and services by networking with key webinar delegates.

• Advertising materials for Psychiatry and Mental Health, including posters, brochures, and pamphlets, will include information for distribution to hospitals, universities, societies, and researchers.

Market Analysis

The global psychiatry market has shown steady growth, driven by increasing awareness of mental health issues and the need for better treatment options. In 2023, the market was valued at approximately $500 billion and is projected to grow to $700 billion by 2028, with a CAGR of 6.5%. In terms of regional growth, North America holds the largest share, representing 45% of the market. The North American psychiatry market is expected to grow from $225 billion in 2023 to $315 billion by 2028. Europe follows closely, contributing 30% of the market, with projections showing growth from $150 billion in 2023 to $210 billion by 2028. The Asia-Pacific region is anticipated to see the fastest growth, with an increase from $75 billion in 2023 to $115 billion by 2028, driven by rising mental health awareness and improved access to care.

Key segments driving this growth include depression, anxiety disorders, bipolar disorder, and schizophrenia, with depression and anxiety representing 40% of the overall market share.Please refer to the graph for a visual representation of the regional market growth forecast from 2023 to 2028.

 

 

To Collaborate Scientific Professionals around the World

Conference Date February 24-25, 2025

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Psychiatry International Journal of Mental Health & Psychiatry Journal of Psychiatry Research and Treatment

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner